Vistagen Therapeutics (VTGN) Preferred Shares (2011 - 2021)
Vistagen Therapeutics (VTGN) reported Preferred Shares of $3,900 for fiscal Q2 2022 (quarter ended Sep 30, 2021), down 2.5% from $4,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Preferred Shares (2011 - 2021) Analysis & Trends
At the end of FY2021 (ended Mar 31, 2021), Vistagen Therapeutics posted Preferred Shares of $4,300, up 7.5% from FY2020.
- Preferred Shares has a five-year compound annual growth rate of -7.9% (FY2016 to FY2021).
- By fiscal year, Preferred Shares came in at $4,000 in FY2020 (unchanged), $4,000 in FY2019 (unchanged), $4,000 in FY2018 (unchanged) and $4,000 in FY2017 (-38.5%).
- Five-year quarterly Preferred Shares spans a low of $3,900 in fiscal Q1 2022 and a high of $5,900 in fiscal Q3 2021.
- Year over year, Preferred Shares gained in two of the last eight quarters, with growth averaging 6.3%.
- The high point for year-over-year Preferred Shares in five years was fiscal Q3 2021 (growth of 47.5%); the low point was fiscal Q4 2017 (a decline of 38.5%).
- Per Business Quant data, the three fiscal quarters before Q2 2022 came in at $3,900 (Q1 2022), $4,300 (Q4 2021) and $5,900 (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Vistagen Therapeutics | 8.39 Mn | -207.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 3,900.00 |
| Jun 30, 2021 | 3,900.00 |
| Mar 31, 2021 | 4,300.00 |
| Dec 31, 2020 | 5,900.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 4,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 4,000.00 |
| Sep 30, 2018 | 4,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Mar 31, 2018 | 4,000.00 |
| Dec 31, 2017 | 4,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Mar 31, 2017 | 4,000.00 |
| Dec 31, 2016 | 4,000.00 |
API Access
Vistagen Therapeutics Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();